CAS: 3881-21-8; 2'-O-Methylinosine

该化合物是一种经过修改的核核素,在异氨酯的肋骨细胞2-氢氧状态上引入了甲基组,这种修改加强了核素的稳定性,防止酶退化,尤其是通过肋骨释放,使其在以RNA为基础的研究和治疗应用中具有价值.2-O-甲基化还提高了对抗感应技术,硅氨和氨酸治疗至关重要的核素的结合性和核素抗性.将其纳入合成RNA结构可以调节药性,减少免疫性.该化合物广泛用于结构研究,核糖酸探针以及生物医学研究中稳定的RNA类.

结构式图片

相似化合物

3181-38-2 58-63-9 3181-38-2

上下游产品

2'-O-methyl adenosine adenosine 1-methyl-1-nitrosourea Inosine 5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-1-propargylinosine-3'-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite 5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-1-propylinosine-3'-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite 5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-1-allylinosine-3'-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite 5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-1-propyl-6-thioinosine-3'-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite

合成工艺路线路线简述

    腺苷置于sodium Hydride,溶剂黄146,Sodium Nitrite体系中,用 N,N-二甲基甲酰胺 用作溶剂,化学反应生成2'-O-甲基肌苷
    参考文献:Antiviral Amphipathic Oligo-And Polyribonucleotides: Analogue Development And Biological Studies
    标题:Antiviral Amphipathic Oligo-And Polyribonucleotides: Analogue Development And Biological Studies
    摘要:A Series Of Novel N1 Alkylated Purine Nucleic Acids Were Polymerized Either Enzymatically Or By Automated Synthesis To Further Establish The Sar Requirements For Hiv,Rt,And Hcmv Activity. Out Of The Series,Two Constructs,2'-O-Methyl-1-Allylinosinic Acid Phosphorothioate 33-Mer (16) And An Oligomer Incorporating 1-Propyl-6-Thioinosinic Acid Residues (20),Were Found To Be Highly Active Under All Three Assay Conditions. Sar Studies Indicate That Sulfur Incorporation,High Molecular Weight,And Low Steric Bulk At N1 All Can Be Important For Activity.
    Doi:10.1021/jm0203276

    海关参考信息

    专利信息


    专利号:US-11858953-B2
    优先权日:2018-04-04
    标 题:Compositions and methods for synthesis of phosphorylated molecules
    发明人:CHAPUT JOHN; LIAO JEN-YU; BALA SAIKAT
    权利人:UNIV CALIFORNIA
    摘要:The invention provides compositions and methods for synthesis of phosphorylated organic compounds, including nucleoside triphosphates.

    专利号:US-2023212204-A1
    优先权日:2020-01-16
    标题:Reagents and their use for modular enantiodivergent synthesis of c-p bonds
    发明人:XU DONGMIN; RIVAS-BASCÓN NAZARET; KNOUSE KYLE W; PADIAL NATALIA; ZHENG BIN; VANTOUROUT JULIEN; SCHMIDT MICHAEL; EASTGATE MARTIN D; BARAN PHI
    权利人:BRISTOL MYERS SQUIBB CO; SCRIPPS RESEARCH INST
    摘要:The disclosure describes chiral P(V)-based reagents and their uses for the modular, scalable, and stereospecific synthesis of chiral phosphines, phosphine oxides and particular oligonucleotides.

    专利号:US-2014378538-A1
    优先权日:2011-12-14
    标 题:Methods of responding to a biothreat
    发明人:BANCEL STEPHANE
    权利人:MODERMA THERAPEUTICS INC
    摘要:The present disclosure provides for devices, in particular mobile devices, which may be used in the synthesis of modified nucleic acid molecules, in particular modified mRNA molecules. The device for making the modified nucleosides, modified nucleotides and modified nucleic acids (e.g., mRNA) disclosed herein may be mobile devices comprising at least one sample block for insertion of one or more sample vessels, a device base with electronic control units for the sample block, a voltage supply, and one or more reagent(s) for the synthesis of at least one nucleic acid.

    专利号:US-9790531-B2
    优先权日:2012-08-14
    标 题 :Enzymes and polymerases for the synthesis of RNA
    发明人:WANG YUXUN; RAMAKRISHNAN DIVAKAR; DE FOUGEROLLES ANTONIN; WHORISKEY SUSAN
    权利人:MODERNATX INC
    摘要:The invention relates to compositions and methods for the design, evolution, preparation, and/or manufacture of enzymes for use with polynucleotides, primary transcripts and mmRNA molecules.

    专利号:US-2025207163-A1
    优先权日:2022-03-25
    标 题:Methods and apparatus for synthesizing nucleic acids
    发明人:HOPKINS PATRYCJA A; SHAHSAVARI SHAHIEN; BEGOYAN VAGARSHAK; NJUMA OLIVE J; DEBENHAM HOLLY S; EFCAVITCH J WILLIAM; ALBIZATI KIM F
    权利人:MOLECULAR ASSEMBLIES INC
    摘要:Methods for the synthesis of polynucleotides using polymerases nucleotide analogs with labile terminator groups that allow stepwise addition of nucleotides are described. These nucleotide analogs may have a modification on 3′, 2′, or 3′-2′-bridged hydroxyl groups or on nucleobase moieties and can be used in the synthesis of natural or modified polynucleotides suitable for use in biological systems. The labile terminator groups are removed under mild conditions or by enzymes. They are accepted as substrates by polymerases. The synthesis may be carried out on a surface.

    专利号:WO-2025101943-A1
    优先权日:2023-11-10
    标 题:Nucleic acid-guided dna synthesis
    发明人:STERNBERG SAMUEL HENRY; TANG STEPHEN; ZHANG DENNIS JAMES; WIEGAND TANNER; THOMAS GEORGE JERRIN; LAMPE GEORGE DAVIS; KANG SHANNON
    权利人:UNIV COLUMBIA
    摘要:The present disclosure provides systems, compositions, methods, and kits, for guided DNA synthesis and genome engineering. Particularly, the present disclosure provides systems, compositions, methods, and kits comprising a defense-associated reverse transcriptase (DRT), or a nucleic acid encoding thereof, and an engineered target nucleic acid comprising one or more sequence of interest, or a nucleic acid encoding thereof.
    上海兆维科技发展有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hongene.com/
    电话: 021-64757213👤
    📞上海兆维科技发展有限公司 ⚠️参考联系方式

    销售电话:021-64757213
    邮箱:info@hongene.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Robak T, Robak P. Purine Nucleoside Analogs In The Treatment Of Rarer Chronic Lymphoid Leukemias. Curr Pharm Des. 2012;18(23):3373-88.

    合成参考文献


    参考文献:10.1038/s41576-025-00861-y
    摘要:Liu JF. CROWN-seq reveals m6Am landscapes and transcription start site diversity. Nat Rev Genet. 2025 Aug;26(8):509. doi: 10.1038/s41576-025-00861-y.
    参考文献:10.1007/s11427-024-2913-7
    摘要:Zhang L, Liu X, Zhang Y, Qin L, Pan S, Yan X, Dong S, Feng Z, Fan SJ, Zhao R, Gao X, Zhao S, Shi J, Zhao H, Zhang Y, Chen ZJ. Peripheral blood RNA modifications as a novel diagnostic signature for polycystic ovary syndrome. Sci China Life Sci. 2025 Nov;68(11):3231–41. doi: 10.1007/s11427-024-2913-7.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知